• LAST PRICE
    0.0850
  • TODAY'S CHANGE (%)
    Trending Down-0.0050 (-5.5556%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0870 / 0.0900
  • Day Range
    Low 0.0850
    High 0.0898
  • 52 Week Range
    Low 0.0780
    High 0.2700
  • Volume
    16,011
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.09
TimeVolumeENZN
10:42 ET150000.085
11:52 ET10000.085
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesENZN
Enzon Pharmaceuticals Inc
6.3M
-26.2x
---
United StatesALZN
Alzamend Neuro Inc
6.4M
-0.4x
---
United StatesVIRI
Virios Therapeutics Inc
6.3M
-0.8x
---
United StatesGNPX
Genprex Inc
6.5M
-0.2x
---
United StatesRASP
Actavia Life Sciences Inc
5.9M
-1.0x
---
United StatesBRTX
BioRestorative Therapies Inc
6.4M
-0.3x
---
As of 2024-02-25

Company Information

Enzon Pharmaceuticals, Inc. (Enzon) is an acquisition vehicle company. The Company intends to become an acquisition platform. The Company utilizes its net operating loss carryforwards (NOLs) and improves stockholder value. It manages its source of royalty revenues from existing licensing arrangements with other companies.

Contact Information

Headquarters
20 Commerce Drive, Suite 135CRANFORD, NJ, United States 07016
Phone
732-980-4500
Fax
302-655-5049

Executives

Independent Chairman of the Board
Randolph Read
Chief Executive Officer, Chief Financial Officer, Secretary
Richard Feinstein
Independent Director
Jordan Bleznick
Independent Director
Jaffery Firestone

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$6.3M
Revenue (TTM)
$26.0K
Shares Outstanding
74.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.32
EPS
$0.00
Book Value
$0.62
P/E Ratio
-26.2x
Price/Sales (TTM)
242.6
Price/Cash Flow (TTM)
---
Operating Margin
-3,996.15%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.